Federal Register / Vol. 74, No. 66 / Wednesday, April 8, 2009 / Notices 15987 

2For purposes of this Notice, ‘‘potential to cause 

an outbreak’’ means the occurrence of more cases 

of disease than could be anticipated in a given area 

or among a specific group of people over a 

particular period of time. In general, and as 

observed through previous experience, an outbreak 

is associated with a public health response. 

vaccinations against vaccinepreventable diseases recommended by 

the Advisory Committee on 

Immunization Practices[(ACIP).]’’ The 

ACIP is a committee chartered under the 

Federal Advisory Committee Act 

(FACA). The ACIP makes vaccine 

recommendations for the U.S. 

population to the CDC Director, who, in 

accordance with FACA, is ultimately 

responsible for accepting, rejecting, or 

modifying those recommendations. Any 

immigrant or applicant applying for 

adjustment of status in the U.S., who is 

unable to present proof of vaccination, 

is inadmissible into the United States 

unless the immigrant or applicant 

receives the required vaccines or applies 

for and receives a statutory waiver. Such 

waivers may be issued if, for example, 

during the medical examination, the 

examiner determines that a vaccination 

is not medically appropriate. 

Since 1996, when the vaccination 

requirement was added to the INA, all 

vaccinations routinely recommended by 

ACIP for the U.S. population have been 

required for immigrants subject to the 

INA vaccination requirement. Although 

this vaccination requirement has been 

in effect since 1996, the continued 

evolution of vaccine development has 

led CDC to reassess the appropriateness 

for each recommended vaccine in the 

context of U.S. immigration in the 

interest of public health. 

Implementation of Specific Vaccination 

Criteria 

The ACIP recommendations regarding 

vaccines are extremely important for 

optimizing individual health status, 

protecting the public health of the 

Nation, and providing technical 

guidance for State-based mandates for 

school, child care, employment and 

other settings. However, to date, the 

ACIP recommendations have been 

applied to persons undergoing medical 

examination for U.S. immigration 

without consideration for the unique 

characteristics of such screening, which 

include the urgency of time in which 

the vaccination is required and the 

location of the individual immigrant, or 

group of immigrants, at the time of the 

medical examination. While the ACIP 

vaccination recommendations are 

appropriate for the general U.S. 

population, CDC is proposing specific 

criteria to determine which ACIPrecommended vaccines are appropriate 

as a requirement at the time and place 

of medical examination for immigration. 

For example, within these criteria, 

vaccinations will be administered to 

applicants if they are considered to be 

‘‘age-appropriate’’ as recommended by 

ACIP for the general U.S. population 

(i.e. the applicant is within the ACIPrecommended age groups of the vaccine 

at the time of the examination). Once it 

is determined that a vaccine is ageappropriate, the vaccine will only be 

administered if it is determined to be 

appropriate in the immigration setting 

due to the potential of diseases to cause 

outbreaks and/or to be introduced into 

the United States, where they have been 

eliminated or are in the process of 

elimination. In contrast, all other ACIP 

recommended vaccines should be 

administered once the applicant is 

admitted to the United States according 

to CDC immunization schedule and 

State-based vaccination mandates. 

Therefore, CDC is proposing to 

implement the vaccination requirements 

provided for in section 212(a)(1)(A)(ii) 

of the INA as follows: Because section 

212(a)(1)(A)(ii) explicitly requires 

vaccinations for listed vaccinepreventable diseases (mumps, measles, 

rubella, polio, tetanus and diphtheria 

toxoids, pertussis, Haemophilus 

influenzae type B and hepatitis B), CDC 

will continue to require those 

vaccinations for immigrants seeking 

admission into the United States or 

seeking to adjust their status to the 

status of legal permanent resident. CDC 

will use the criteria below for 

determining which additional vaccines 

recommended by ACIP for the general 

population will be required for such 

immigrants. All vaccines will remain 

subject to statutory waivers, if 

applicable. In addition, CDC will review 

the list of vaccines recommended by 

ACIP for the general U.S. population on 

a regular basis and apply the specific 

criteria to determine which additional 

vaccines will be required for U.S. 

immigration purposes. 

CDC proposes to use the following 

criteria: 

1. The vaccine must be an ageappropriate vaccine as recommended by 

ACIP for the general U.S. population, 

and 

2. At least one of the following: 

a. The vaccine must protect against a 

disease that has the potential to cause 

an outbreak.2

b. The vaccine must protect against a 

disease that has been eliminated in the 

United States, or is in the process for 

elimination in the United States. 

Through the issuance of revised 

Technical Instructions and other 

standard operating procedures, CDC 

upon application of the criteria will 

notify the panel physicians and civil 

surgeons who conduct the medical 

examination of any changes to the 

vaccination requirements for U.S. 

immigration purposes. 

Dated: April 1, 2009. 

James D. Seligman, 

Chief Information Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E9–7934 Filed 4–7–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Office of Community Services; Notice 

To Award a Non-Competitive 

Successor Grant to Neighborhood 

Assets 

AGENCY: Administration for Children 

and Families (ACF), Department of 

Health and Human Services (HHS). 

ACTION: Notice to award a noncompetitive successor grant to 

Neighborhood Assets. 

CFDA#: 93.602. 

Project Period: September 30, 2004 to 

September 29, 2009. 

Award Amount: 100,000. 

Statutory Authority: The Assets for 

Independence Act (Title IV of the 

Community Opportunities, Accountability, 

and Training and Educational Act of 1998, as 

amended, Pub. L. 105–285, 42 U.S.C. 604 

note). 

SUMMARY: Notice is hereby given that 

the Administration for Children and 

Families (ACF), Office of Community 

Services (OCS) will award a noncompetitive successor grant to 

Neighborhood Assets, a non-profit 

organization located in Spokane, 

Washington. The Assets for 

Independence program supports 

grantees that provide low-income 

individuals and families with access to 

special matched savings accounts called 

individual development accounts (IDAs) 

and other asset-building tools such as 

financial literacy education and 

coaching and training on money 

management and consumer issues. The 

award will enable the Neighborhood 

Assets to implement an Assets for 

Independence project serving lowincome families in Spokane, 

Washington. This action is taken as the 

original grantee, Spokane Neighborhood 

Action Programs, has relinquished the 

grant. 

FOR FURTHER INFORMATION CONTACT: Mr. 

James Gatz, Manager, Assets for 


rwilkins on PROD1PC63 with NOTICES
15988 Federal Register / Vol. 74, No. 66 / Wednesday, April 8, 2009 / Notices 

Independence Program, Office of 

Community Services, Administration 

for Children and Families, 370 L’Enfant 

Promenade, SW., Washington, DC 

20447, by telephone on (202) 401–4626 

or by e-mail at AFIprogram@acf.hhs.gov. 

Dated: March 23, 2009. 

Yolanda J. Butler, 

Acting Director, Office of Community 

Services. 

[FR Doc. E9–7999 Filed 4–7–09; 8:45 am] 

BILLING CODE 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Office of Community Services; Notice 

To Award a Non-Competitive 

Successor Grant to Neighborhood 

Assets 

AGENCY: Administration for Children 

and Families (ACF), Department of 

Health and Human Services (HHS). 

ACTION: Notice to award a noncompetitive successor grant to 

Neighborhood Assets. 

CFDA#: 93.602. 

Project Period: September 30, 2004 to 

September 29, 2009. 

Award Amount: 35,000. 

Statutory Authority: The Assets for 

Independence Act (Title IV of the 

Community Opportunities, Accountability, 

and Training and Educational Act of 1998, as 

amended, Public Law 105–285, 42 U.S.C. 604 

note). 

SUMMARY: Notice is hereby given that 

the Administration for Children and 

Families (ACF), Office of Community 

Services (OCS) will award a noncompetitive successor grant to 

Neighborhood Assets, a non-profit 

organization located in Spokane, 

Washington. The Assets for 

Independence program supports 

grantees that provide low-income 

individuals and families with access to 

special matched savings accounts called 

individual development accounts (IDAs) 

and other asset-building tools such as 

financial literacy education and 

coaching and training on money 

management and consumer issues. The 

award will enable the Neighborhood 

Assets to implement an Assets for 

Independence project serving lowincome families in Spokane, 

Washington. This action is taken as the 

original grantee, Spokane Neighborhood 

Action Programs, has relinquished the 

grant. 

FOR FURTHER INFORMATION CONTACT: Mr. 

James Gatz, Manager, Assets for 

Independence Program, Office of 

Community Services, Administration 

for Children and Families, 370 L’Enfant 

Promenade, SW., Washington, DC 

20447, by telephone on (202) 401–4626 

or by e-mail at AFIprogram@acf.hhs.gov. 

Dated: March 23, 2009. 

Yolanda J. Butler, 

Acting Director, Office of Community 

Services. 

[FR Doc. E9–8005 Filed 4–7–09; 8:45 am] 

BILLING CODE 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–N–0490] 

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

Voluntary Cosmetic Registration 

Program 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a collection of information entitled 

‘‘Voluntary Cosmetic Registration 

Program’’ has been approved by the 

Office of Management and Budget 

(OMB) under the Paperwork Reduction 

Act of 1995. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of Information 

Management (HFA–710), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–796–3794. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of December 16, 2008 

(73 FR 76360), the agency announced 

that the proposed information collection 

had been submitted to OMB for review 

and clearance under 44 U.S.C. 3507. An 

agency may not conduct or sponsor, and 

a person is not required to respond to, 

a collection of information unless it 

displays a currently valid OMB control 

number. OMB has now approved the 

information collection and has assigned 

OMB control number 0910–0030. The 

approval expires on February 29, 2012. 

A copy of the supporting statement for 

this information collection is available 

on the Internet at http:// 

www.reginfo.gov/public/do/PRAMain. 

Dated: April 1, 2009. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E9–7878 Filed 4–7–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–N–0397] 

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

State Enforcement Notifications 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a collection of information entitled 

‘‘State Enforcement Notifications’’ has 

been approved by the Office of 

Management and Budget (OMB) under 

the Paperwork Reduction Act of 1995. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of Information 

Management (HFA–710), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–796–3794. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of November 18, 2008 

(73 FR 68430), the agency announced 

that the proposed information collection 

had been submitted to OMB for review 

and clearance under 44 U.S.C. 3507. An 

agency may not conduct or sponsor, and 

a person is not required to respond to, 

a collection of information unless it 

displays a currently valid OMB control 

number. OMB has now approved the 

information collection and has assigned 

OMB control number 0910–0275. The 

approval expires on March 31, 2012. A 

copy of the supporting statement for this 

information collection is available on 

the Internet at http://www.reginfo.gov/ 

public/do/PRAMain. 

Dated: April 1, 2009. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E9–7906 Filed 4–7–09; 8:45 am] 

BILLING CODE 4160–01–S 


rwilkins on PROD1PC63 with NOTICES